Differences in kinetics of xanomeline binding and selectivity of activation of G proteins at M1 and M2 muscarinic acetylcholine receptors

被引:47
|
作者
Jakubik, Jan
El-Fakahany, Esam E.
Dolezal, Vladimir
机构
[1] Acad Sci Czech Republ, Dept Neurochem, Inst Physiol, Prague 14220, Czech Republic
[2] Univ Minnesota, Sch Med, Div Neurosci Res Psychiat, Minneapolis, MN 55455 USA
关键词
D O I
10.1124/mol.106.023762
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Xanomeline is a functionally selective M-1/M-4 muscarinic acetylcholine receptor agonist that nevertheless binds with high affinity to all five subtypes of muscarinic receptors. A novel mode of interaction of this ligand with the muscarinic M-1 receptors characterized by persistent binding and receptor activation after extensive washout has been shown previously. In the present study, using human M-1 and M-2 receptors expressed in Chinese hamster ovary cells and [H-3]N-methylscopolamine as a tracer, we show that persistent binding of xanomeline also occurs at the M-2 receptor with similar affinity as at the M-1 receptor (K-I = 294 and 296 nM, respectively). However, kinetics of formation of xanomeline wash-resistant binding to M-2 receptors was markedly slower than to M-1 receptors. Xanomeline was a potent fast-acting full agonist in stimulating guanosine 5'-O-(3-[S-35]thio) triphosphate binding at M-1 receptors, whereas at M-2 receptors it behaved as a potent partial agonist (40% of carbachol maximal response) only upon preincubation for 1 h. Development of xanomeline agonistic effects at the M-2 receptor was slower than its ability to attenuate carbachol responses. We also demonstrate that xanomeline discriminates better between G protein subtypes at M-1 than at M-2 receptors. Our data support the notion that xanomeline interacts with multiple sites on the muscarinic receptor, resulting in divergent conformations that exhibit differential effects on ligand binding and receptor activation. These conformations are both time- and concentration-dependent and vary between the M-1 and the M-2 receptor.
引用
收藏
页码:656 / 666
页数:11
相关论文
共 50 条
  • [22] CHIMERIC M1/M2 MUSCARINIC RECEPTORS - CORRELATION OF LIGAND SELECTIVITY AND FUNCTIONAL COUPLING WITH STRUCTURAL MODIFICATIONS
    LAI, J
    NUNAN, L
    WAITE, SL
    MA, SW
    BLOOM, JW
    ROESKE, WR
    YAMAMURA, HI
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1992, 262 (01): : 173 - 180
  • [23] Muscarinic M1 and M2 receptors, fasting and seizure development in animals
    Bacanak, Merve Saygi
    [J]. CLINICAL AND EXPERIMENTAL HEALTH SCIENCES, 2018, 8 (04): : 308 - 313
  • [24] THE ROLE OF MUSCARINIC M1 AND M2 RECEPTORS IN AIRWAY CONSTRICTION IN THE CAT
    KILLINGSWORTH, CR
    ROBINSON, NE
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 210 (03) : 231 - 238
  • [25] The interaction of lipophilic quaternary carbamates with M1 and M2 muscarinic receptors
    Amitai, G
    Adani, R
    Sod-Moriah, G
    Rachman, E
    Heldman, E
    [J]. NEUROSCIENCE LETTERS, 1997, : S3 - S3
  • [26] XANOMELINE - A NOVEL MUSCARINIC RECEPTOR AGONIST WITH FUNCTIONAL SELECTIVITY FOR M(1) RECEPTORS
    SHANNON, HE
    BYMASTER, FP
    CALLIGARO, DO
    GREENWOOD, B
    MITCH, CH
    SAWYER, BD
    WARD, JS
    WONG, DT
    OLESEN, PH
    SHEARDOWN, MJ
    SWEDBERG, MDB
    SUZDAK, PD
    SAUERBERG, P
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1994, 269 (01): : 271 - 281
  • [27] Effects of anandamide on the binding and signaling properties of M1 muscarinic acetylcholine receptors
    Lanzafame, AA
    Guida, E
    Christopoulos, A
    [J]. BIOCHEMICAL PHARMACOLOGY, 2004, 68 (11) : 2207 - 2219
  • [28] Novel persistent activation of muscarinic M-1 receptors by xanomeline
    Christopoulos, A
    ElFakahany, EE
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 334 (01) : R3 - R4
  • [29] Binding and functional characterisation of allosteric agonists at M2 muscarinic acetylcholine receptors
    Gregory, Karen Joan
    Hall, Nathan E.
    Sexton, Patrick M.
    Christopoulos, Arthur
    [J]. FASEB JOURNAL, 2008, 22
  • [30] Wash-resistantly bound xanomeline inhibits acetylcholine release by persistent activation of presynaptic M2 and M4 muscarinic receptors in rat brain
    Machova, E.
    Jakubik, J.
    El-Fakahany, E. E.
    Dolezal, V.
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2007, 322 (01): : 316 - 323